Suppr超能文献

高分辨率探测与阿尔茨海默病相关的淀粉样β聚集的早期事件。

High-resolution probing of early events in amyloid-β aggregation related to Alzheimer's disease.

机构信息

Biophysics Program, Department of Chemistry, University of Michigan, Ann Arbor, MI 48109-1055, USA.

出版信息

Chem Commun (Camb). 2020 Apr 30;56(34):4627-4639. doi: 10.1039/d0cc01551b. Epub 2020 Apr 17.

Abstract

In Alzheimer's disease (AD), soluble oligomers of amyloid-β (Aβ) are emerging as a crucial entity in driving disease progression as compared to insoluble amyloid deposits. The lacuna in establishing the structure to function relationship for Aβ oligomers prevents the development of an effective treatment for AD. While the transient and heterogeneous properties of Aβ oligomers impose many challenges for structural investigation, an effective use of a combination of NMR techniques has successfully identified and characterized them at atomic-resolution. Here, we review the successful utilization of solution and solid-state NMR techniques to probe the aggregation and structures of small and large oligomers of Aβ. Biophysical studies utilizing the commonly used solution and F based NMR experiments to identify the formation of small size early intermediates and to obtain their structures, and dock-lock mechanism of fiber growth at atomic-resolution are discussed. In addition, the use of proton-detected magic angle spinning (MAS) solid-state NMR experiments to obtain high-resolution insights into the aggregation pathways and structures of large oligomers and other aggregates is also presented. We expect these NMR based studies to be valuable for real-time monitoring of the depletion of monomers and the formation of toxic oligomers and high-order aggregates under a variety of conditions, and to solve the high-resolution structures of small and large size oligomers for most amyloid proteins, and therefore to develop inhibitors and drugs.

摘要

在阿尔茨海默病(AD)中,与不溶性淀粉样沉积物相比,可溶性淀粉样β(Aβ)寡聚体作为驱动疾病进展的关键实体而出现。由于缺乏建立 Aβ寡聚体结构-功能关系的方法,因此无法开发出有效的 AD 治疗方法。虽然 Aβ寡聚体的瞬态和异质性质对结构研究提出了许多挑战,但联合使用 NMR 技术的有效方法已成功在原子分辨率水平上对其进行了鉴定和表征。在这里,我们回顾了成功利用溶液和固态 NMR 技术来研究 Aβ小分子和大分子寡聚体的聚集和结构。利用常用的溶液和 F 基 NMR 实验进行生物物理研究,以确定小尺寸早期中间产物的形成并获得其结构,并讨论了纤维生长的对接锁定机制在原子分辨率水平上的作用。此外,还介绍了质子探测魔角旋转(MAS)固态 NMR 实验在获得大寡聚体和其他聚集体的聚集途径和结构的高分辨率见解方面的应用。我们期望这些基于 NMR 的研究对于实时监测各种条件下单体的消耗和有毒寡聚体和高序聚集体的形成具有重要价值,并解决大多数淀粉样蛋白中小分子和大分子尺寸寡聚体的高分辨率结构问题,从而开发出抑制剂和药物。

相似文献

引用本文的文献

本文引用的文献

6
Structure-Based Peptide Inhibitor Design of Amyloid-β Aggregation.基于结构的β淀粉样蛋白聚集肽抑制剂设计
Front Mol Neurosci. 2019 Mar 4;12:54. doi: 10.3389/fnmol.2019.00054. eCollection 2019.
9
A new era for understanding amyloid structures and disease.理解淀粉样结构和疾病的新纪元。
Nat Rev Mol Cell Biol. 2018 Dec;19(12):755-773. doi: 10.1038/s41580-018-0060-8.
10
Understanding the Role of ApoE Fragments in Alzheimer's Disease.了解载脂蛋白 E 片段在阿尔茨海默病中的作用。
Neurochem Res. 2019 Jun;44(6):1297-1305. doi: 10.1007/s11064-018-2629-1. Epub 2018 Sep 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验